An overview of the inactivation of FMDV and the implications when residual virus is present in vaccines. Brown, F. In Developments in Biological Standardization, volume 75, pages 37-41, 1991. bibtex @inproceedings{
title = {An overview of the inactivation of FMDV and the implications when residual virus is present in vaccines},
type = {inproceedings},
year = {1991},
identifiers = {[object Object]},
pages = {37-41},
volume = {75},
id = {63848f1c-2c05-3072-97c0-d5abae47a9e7},
created = {2020-09-30T20:09:25.368Z},
accessed = {2020-09-30},
file_attached = {false},
profile_id = {f7328406-3e7e-3e37-9ea0-01d7cb781b09},
group_id = {3455ce01-3ebd-33b1-bddf-c7304973b8e6},
last_modified = {2020-09-30T20:09:25.580Z},
read = {false},
starred = {false},
authored = {false},
confirmed = {false},
hidden = {false},
folder_uuids = {9a808871-8498-4eda-bd89-d4a475cdd385},
private_publication = {false},
bibtype = {inproceedings},
author = {Brown, F.},
booktitle = {Developments in Biological Standardization}
}
Downloads: 0
{"_id":"bm2vZcdcmS44xxE9d","bibbaseid":"brown-anoverviewoftheinactivationoffmdvandtheimplicationswhenresidualvirusispresentinvaccines-1991","authorIDs":[],"author_short":["Brown, F."],"bibdata":{"title":"An overview of the inactivation of FMDV and the implications when residual virus is present in vaccines","type":"inproceedings","year":"1991","identifiers":"[object Object]","pages":"37-41","volume":"75","id":"63848f1c-2c05-3072-97c0-d5abae47a9e7","created":"2020-09-30T20:09:25.368Z","accessed":"2020-09-30","file_attached":false,"profile_id":"f7328406-3e7e-3e37-9ea0-01d7cb781b09","group_id":"3455ce01-3ebd-33b1-bddf-c7304973b8e6","last_modified":"2020-09-30T20:09:25.580Z","read":false,"starred":false,"authored":false,"confirmed":false,"hidden":false,"folder_uuids":"9a808871-8498-4eda-bd89-d4a475cdd385","private_publication":false,"bibtype":"inproceedings","author":"Brown, F.","booktitle":"Developments in Biological Standardization","bibtex":"@inproceedings{\n title = {An overview of the inactivation of FMDV and the implications when residual virus is present in vaccines},\n type = {inproceedings},\n year = {1991},\n identifiers = {[object Object]},\n pages = {37-41},\n volume = {75},\n id = {63848f1c-2c05-3072-97c0-d5abae47a9e7},\n created = {2020-09-30T20:09:25.368Z},\n accessed = {2020-09-30},\n file_attached = {false},\n profile_id = {f7328406-3e7e-3e37-9ea0-01d7cb781b09},\n group_id = {3455ce01-3ebd-33b1-bddf-c7304973b8e6},\n last_modified = {2020-09-30T20:09:25.580Z},\n read = {false},\n starred = {false},\n authored = {false},\n confirmed = {false},\n hidden = {false},\n folder_uuids = {9a808871-8498-4eda-bd89-d4a475cdd385},\n private_publication = {false},\n bibtype = {inproceedings},\n author = {Brown, F.},\n booktitle = {Developments in Biological Standardization}\n}","author_short":["Brown, F."],"bibbaseid":"brown-anoverviewoftheinactivationoffmdvandtheimplicationswhenresidualvirusispresentinvaccines-1991","role":"author","urls":{},"downloads":0},"bibtype":"inproceedings","creationDate":"2020-10-03T03:35:58.266Z","downloads":0,"keywords":[],"search_terms":["overview","inactivation","fmdv","implications","residual","virus","present","vaccines","brown"],"title":"An overview of the inactivation of FMDV and the implications when residual virus is present in vaccines","year":1991}